Shares of Allscripts ( MDRX) , a provider of practice management and electronic health record technology to various healthcare professions, were climbing over 2% during early Tuesday morning trading following an upgrade of the stock at Cantor Fitzgerald.

The firm raised its rating on the stock to "Overweight" from "Neutral" and hiked its price target to $17 from $15.

Allscripts's acquisition of McKesson's ( MCK) Enterprise Information Solutions health IT business for $185 million in cash earlier this month will fill some product gaps and generate material cost saving opportunities for the firm, Cantor analyst Steven Halper. He also sees an improved risk/reward offering.

More of What's Trending on TheStreet:

If you liked this article you might like

Analysts' Actions -- Adobe, Starbucks, Snap, KB Home and More

Allscripts (MDRX) Stock Stumbles as Q3 Results Miss Expectations

Analysts' Actions -- Chipotle, Darden, McDonald's, Square and More

Allscripts (MDRX) Stock Lower After Q2 Revenue Miss